Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease.
Saved in:
| Title: | Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease. |
|---|---|
| Authors: | Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan., Batterham RL; Eli Lilly and Company, Basingstoke, UK., Liu-Seifert H; Eli Lilly and Company, Indianapolis, IN, USA., Li R; Eli Lilly and Company, Indianapolis, IN, USA., Yoshino M; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Oura T; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Tanizawa Y; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Komuro I; Department of Frontier Cardiovascular Science, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; International University of Health and Welfare, Tokyo, Japan. |
| Source: | Current medical research and opinion [Curr Med Res Opin] 2026 Apr; Vol. 42 (4), pp. 751-763. Date of Electronic Publication: 2026 Jun 13. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1473-4877 |
|---|---|
| DOI: | 10.1080/03007995.2026.2686052 |
